First Trust NYSE Arca Biotechnology Index Fund
63 hedge funds and large institutions have $287M invested in First Trust NYSE Arca Biotechnology Index Fund in 2013 Q2 according to their latest regulatory filings, with 63 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
85.09% more ownership
Funds ownership: 0% → 85.09% (+85%)
16% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $1.52M
Top Buyers
Top Sellers
FBT Hedge Fund Activity: Q2 2013 in Review
63 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q2 2013, worth a combined $287M.
Buyers outnumbered sellers: 63 funds opened new FBT positions and 0 closed out — a net gain of 63 holders — while 0 added to existing stakes and 0 trimmed.
- 63 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $287M of First Trust NYSE Arca Biotechnology Index Fund stock for Q2 2013.
- 63 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q2 2013 and 0 closed out, a net change of +63 holders.
Based on aggregated 13F filings for Q2 2013.